<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02307942</url>
  </required_header>
  <id_info>
    <org_study_id>13 7051 01</org_study_id>
    <secondary_id>13705101</secondary_id>
    <nct_id>NCT02307942</nct_id>
  </id_info>
  <brief_title>Improvement in Physical Performance and Obesity Surgery in Patients Older Than 60 Years</brief_title>
  <acronym>ELDSURG</acronym>
  <official_title>Does Intense Weight Loss Improve Physical Performance in Obese Patients Older Than 60 Yrs Undergoing Exercise Training? Comparison Between Surgery and Standard of Care.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to compare the efficacy of two weight losing strategies
      (obesity surgery with gastric banding, and standard of care) on physical performance in
      elderly obese persons submitted to a physical training. Our hypothesis is that a
      surgery-induced weight loss in the context of a physical training (which is recommended in
      people 60-75 yrs losing weight) improves physical performance as compared to standard of care
      (3-5% weight loss).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized clinical trial; Single Blind A physical training is recommended in people above 60
      yrs. engaged in a weight-losing program, in order to prevent the impairment of physical
      performance. Therefore a physical training program (endurance and strength training) will be
      implemented for all subjects participating in the study, starting 1 month before
      randomization. It will last for 13 months. Patients will be randomized either in the surgical
      group (gastric banding under general anesthesia) or in the reference group (mild calorie
      restriction and coaching). Physical performance of patients is evaluated at screening,
      inclusion, at randomization, 6 and 12 months after randomization.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physical performance</measure>
    <time_frame>12 months, comparing to the 6 months assesment</time_frame>
    <description>Short Physical Performance Battery score (SPPB)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical performance</measure>
    <time_frame>At randomization, 6 and 12 months later</time_frame>
    <description>the components of the SPPB score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>weight loss</measure>
    <time_frame>At randomization, 6 and 12 months later</time_frame>
    <description>kg, and % of initial weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composition of weight loss</measure>
    <time_frame>At randomization, 6 and 12 months later</time_frame>
    <description>% of weight lost as lean mass, as fat mass, changes in appendicular skeletal muscle mass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in muscle strength</measure>
    <time_frame>At randomization, 6 and 12 months later</time_frame>
    <description>strain gauge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in aerobic fitness</measure>
    <time_frame>At randomization, 6 and 12 months later</time_frame>
    <description>maximal aerobic capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early complications</measure>
    <time_frame>At randomization, 6 and 12 months later</time_frame>
    <description>in operated patients : number of hospital re-admissions, number of deep venous thrombosis, number of pulmonary embolism, food intake (calories, protein, eating difficulties</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calorie and protein intake</measure>
    <time_frame>At randomization, 6 and 12 months later</time_frame>
    <description>dietary survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>At randomization, 6 and 12 months later</time_frame>
    <description>Nottingham quality of life score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability</measure>
    <time_frame>At randomization, 6 and 12 months later</time_frame>
    <description>Functional Status Questionnaire score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>At randomization, 6 and 12 months later</time_frame>
    <description>MMSE</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>SURGERY</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will be operated for a gastric banding disposal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>STANDARD</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care for obesity</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gastric banding</intervention_name>
    <description>The bariatric procedure is a gastric banding under general anesthesia with all the centres using the same surgical procedure (harmonized by group meetings). The laparoscopic surgical procedure has been described. The ERAS protocol will be applied in each centre. The inflation of the band will follow the procedures described by 0'Brien. The patients will attend a group education session before surgery, during which the eating behaviour with a band will be explained and practiced. Then after surgery, the routine procedure is applied.</description>
    <arm_group_label>SURGERY</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Criteria specific to the study Subjects aged 60 or over and younger than 75 yrs., seeking
        obesity treatments, seeking obesity surgery, with a BMI of 30 kg/m² or more, with
        comorbidities (see below), and a mildly decreased physical performance (SPPB between 5 and
        8) are considered to participate in the study Criteria specific to obesity surgery This
        projects extends the classical recommendation for obesity surgery to people with a BMI of
        30 and over with either the comorbidities list below, or a SPPB between 5 and 8. This level
        of physical impairment can be considered as a comorbidity in the elderly.

        The French Ministry of health (HAS) recommends that obesity surgery be considered (here
        with a gastric banding) in patients fulfilling the following criteria:

          -  Subjects with a BMI of 40kg/m² or more, or 35kg/m² or more if at least one comorbidity
             that can be improved by weight loss is present among hypertension, obstructive sleep
             apnea, severe metabolic disorder (such as type 2 diabetes, NASH), or rheumatologic
             conditions associated with disability.

          -  After the failure of well designed medical, dietetic, psychological intervention
             followed up for 6-12 months, with no sufficient weight loss or in case of the failure
             of maintaining weight loss

          -  In subjects well informed of the consequences of surgery, and after a
             multi-disciplinary evaluation

          -  Subjects have understood and accepted the need for a long term medical and surgical
             follow up

          -  The risk of surgery is acceptable

          -  patient who signed the informed consent

          -  patient affiliated to a social security cover or equivalent

        Exclusion Criteria:

        Criteria specific to the study

          -  These are the impossibility to follow a physical training (unstable coronary heart
             disease, severe lung function impairment, rheumatologic conditions preventing
             training, a SPPB score below 5, cancer treatment within the 3 last months, Parkinson's
             disease, other severe illness that may interfere with physical activity) Criteria
             specific to gastric banding

          -  Cognitive impairment (MMSE ≤ 25)

          -  Severe eating disorder

          -  Impossible long-term follow-up

          -  Alcohol or drug dependence

          -  Lack of previous well designed obesity care

          -  Vital prognosis engaged in the short term

          -  Contra-indications to anaesthesia Classical criteria for the non inclusion in a trial

          -  The subject is in jail, or has freedom restriction

          -  Guardianship curators or judicial protection

          -  Patients participating in another intervention study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick RITZ, MD; PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Toulouse, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick RITZ, MD; PHD</last_name>
    <phone>33 567771638</phone>
    <email>ritz.p@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emmanuelle LAMI, MSc</last_name>
    <phone>33 561323361</phone>
    <email>lami.e@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinique de l'ANJOU</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe TOPART, MD</last_name>
      <phone>33 2 41 48 54 99</phone>
    </contact>
    <investigator>
      <last_name>Philippe TOPART, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume BECOUARN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franck HAMARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Agnès SALLE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital louis Mourier</name>
      <address>
        <city>Colombes</city>
        <zip>92701</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Simon MSIKA, MD; PHD</last_name>
      <phone>33 1 47 60 63 81</phone>
      <email>simon.msika@lmr.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Simon MSIKA, MD; PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hawa KEITA-MEYER, MD; PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Muriel COUPAYE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de LILLE</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>François PATTOU, MD; PhD</last_name>
      <phone>33 3 20 44 42 73</phone>
      <email>fpattou@univ-lille2.fr</email>
    </contact>
    <investigator>
      <last_name>François PATTOU, MD; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert CAIAZZO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hélène VERKINDT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maire PIGEYRE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilles LEBUFFE, MD; PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de LYON</name>
      <address>
        <city>Lyon</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martine LAVILLE, MD; PhD</last_name>
      <phone>33426235917</phone>
      <email>martine.laville@univ-lyon1.fr</email>
    </contact>
    <investigator>
      <last_name>Martine LAVILLE, MD; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel DISSE, MD; PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chantal SIMON, MD; PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maud ROBERT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mary-Charlotte LE GOFF, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michel KREMPF, MD; PhD</last_name>
      <phone>33 2 53 48 27 01</phone>
      <email>michel.krempf@univ-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Michel KREMPF, MD; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric LETESSIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Pierre FRABOUL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HEGP</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Marc CHEVALLIER, MD; PHD</last_name>
      <phone>33 1 56 09 35 37</phone>
      <email>jean-marc.chevallier@egp.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Marc CHEVALLIER, MD; PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Jacques ALTMAN, MD; PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Denis SAFRAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick RITZ, MD; PhD</last_name>
      <email>ritz.p@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Yves ROLLAND, MD; PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Ritz, MD; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno VELLAS, MD; PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilles FOURTANIER, MD; PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mael Chalret du Rieu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier FOURCADE, MD; PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danièle RIVIERE, MD; PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabien PILLARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana ESTRADE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte VAURS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne GHISOLFI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hélène HANAIRE, MD; PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gisèle HERNANDEZ, MD; PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37. Review. Erratum in: JAMA. 2005 Apr 13;293(14):1728.</citation>
    <PMID>15479938</PMID>
  </reference>
  <reference>
    <citation>Chevallier JM, Zinzindohoué F, Douard R, Blanche JP, Berta JL, Altman JJ, Cugnenc PH. Complications after laparoscopic adjustable gastric banding for morbid obesity: experience with 1,000 patients over 7 years. Obes Surg. 2004 Mar;14(3):407-14.</citation>
    <PMID>15072664</PMID>
  </reference>
  <reference>
    <citation>O'Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013 Jan;257(1):87-94. doi: 10.1097/SLA.0b013e31827b6c02. Review.</citation>
    <PMID>23235396</PMID>
  </reference>
  <reference>
    <citation>Mittermair RP, Obermüller S, Perathoner A, Sieb M, Aigner F, Margreiter R. Results and complications after Swedish adjustable gastric banding-10 years experience. Obes Surg. 2009 Dec;19(12):1636-41. doi: 10.1007/s11695-009-9967-7.</citation>
    <PMID>19763708</PMID>
  </reference>
  <reference>
    <citation>Chevallier JM, Paita M, Rodde-Dunet MH, Marty M, Nogues F, Slim K, Basdevant A. Predictive factors of outcome after gastric banding: a nationwide survey on the role of center activity and patients' behavior. Ann Surg. 2007 Dec;246(6):1034-9.</citation>
    <PMID>18043107</PMID>
  </reference>
  <reference>
    <citation>Gagner M, Milone L, Yung E, Broseus A, Gumbs AA. Causes of early mortality after laparoscopic adjustable gastric banding. J Am Coll Surg. 2008 Apr;206(4):664-9. doi: 10.1016/j.jamcollsurg.2007.11.014. Epub 2008 Jan 28. Review.</citation>
    <PMID>18387472</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2014</study_first_submitted>
  <study_first_submitted_qc>December 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2014</study_first_posted>
  <last_update_submitted>March 5, 2017</last_update_submitted>
  <last_update_submitted_qc>March 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Randomized Clinical Trials</keyword>
  <keyword>gastric banding</keyword>
  <keyword>calorie restriction</keyword>
  <keyword>SPPB</keyword>
  <keyword>physical performance</keyword>
  <keyword>elderly</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

